Biotech

All Articles

Novo Nordisk centers once-monthly GLP-1\/ GIP agonist, MASH possibility

.Novo Nordisk has axed its once-monthly dual GLP-1/ GIP receptor agonist, finishing (PDF) progressio...

Daiichi pays out Merck $170M to form lung cancer cells T-cell engager deal

.Merck &amp Co. has promptly gotten back several of the prices of its Harpoon Therapies buyout, attr...

BioMarin halts preclinical genetics therapy for heart disease

.After BioMarin carried out a spring season clean of its pipeline in April, the company has decided ...

Eisai vegetations molecular glue SEED with $1.5 B biobucks deal

.Major Pharmas remain stuck to the idea of molecular glue degraders. The latest firm to see an optio...

Life science credit scores organization reveals along with $600M

.A brand new worldwide life scientific research credit history organization, referred to as Symbioti...

BMS trenches TIGIT, leaving $200M bet on Agenus bispecific

.Bristol Myers Squibb is actually axing an additional large wager from the Caforio period, canceling...

Nuvation halts wager inhibitor after thinking about period 1 record

.After looking at phase 1 data, Nuvation Bio has chosen to stop deal with its single top BD2-selecti...

' Professional intuition' led FDA specialists to back Zevra's uncommon illness med

.Zevra Rehabs' uncommon illness medicine seems to be to be on the pathway to authorization this fall...

Pfizer takes $230M attacked after axing fell short DMD genetics treatment

.Pfizer's period 3 Duchenne muscular dystrophy (DMD) gene treatment failing has blown a $230 thousan...

AC Immune finds 'landmark' potential in Alzheimer's drug information

.After greater than two decades of work with neurodegenerative illness, Swiss biotech air conditioni...